Who founded Qentoros?

Qentoros was founded by Jessica Gilbertie in 2022.

How much funding has Qentoros raised?

Qentoros has disclosed $605K raised across 2 rounds.

Where is Qentoros headquartered?

Qentoros is headquartered in Blacksburg, US.

Qentoros

Blacksburg, US · Founded 2022 · Virginia corporation

Find your way into Qentoros

626 people in our graph share verified history with the Qentoros team — schools, employers, funds. One of them is your warm intro.

Michelle Kincaidunlockedknows MICHAEL MILLER · together at The Roanoke Times (overlapped)

knows the team · via General Dynamics Information Technology

×2knows the team · via North Carolina State University

×8knows the team · via Virginia Tech

Qentoros develops peptide biologic therapeutics for veterinary medicine through its Q-Biologics platform, with the first product BIO-PLY™ in FDA development for infectious, inflammatory, and degenerative diseases.

AgTech Biotech Healthtech Medical Devices

Founders & leadership

Qentoros was founded in 2022 by Jessica Gilbertie.

Jessica Gilbertie Founder and Chief Executive OfficerDr. Gilbertie holds a BS/MS from Virginia Tech, a DVM from Iowa State University, and a PhD from North Carolina State University's College of Veterinary Medicine. She is an Associate Professor of Microbiology at the Virginia Maryland College of Veterinary Medicine and founded Qentoros, where she leads research and development of peptide biologic therapeutics for infectious, inflammatory, and degenerative diseases.

MICHAEL MILLER Director of Intellectual PropertyMichael Miller is a retired senior innovations officer from Virginia Tech and Cleveland Clinic Innovations who has held positions in intellectual property management and technical writing, and currently serves as Executive Officer and Director at Qentoros.

Lauren Schnabel Chief Medical OfficerLauren Schnabel is a Professor of Equine Orthopedic Surgery at North Carolina State University College of Veterinary Medicine, where she also co-directs the NIH-funded Comparative Medicine and Translational Research Program. She holds a DVM and PhD from Cornell University, completed a large animal surgery residency, and is board-certified in veterinary surgery and sports medicine, with research interests in stem cell immunology and biologic therapies for musculoskeletal injury.

Board

JOHN SCHOTTBoard director

MICHAEL ABBOTTBoard director

Reported raises · per SEC filings

Form D private placements

$605K disclosed across 2 rounds · 2025–2026

▶$100KraisedAug 2026 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

JESSICA GILBERTIEExecutive Officer, Director
MICHAEL MILLERDirector
JOHN SCHOTTDirector
MICHAEL ABBOTTDirector

Offering amount: $2M
Amount sold: $100K
Minimum investment: $25K
First sale: Dec 2025
Incorporated: Corporation, Virginia, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$505KraisedAug 2026 · 9 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

JESSICA GILBERTIEExecutive Officer, Director
MICHAEL MILLERDirector
JOHN SCHOTTDirector
MICHAEL ABBOTTDirector

Offering amount: $1.3M
Amount sold: $505K
First sale: Apr 2026
Incorporated: Corporation, Virginia, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Qentoros do?: Qentoros develops peptide biologic therapeutics for veterinary medicine through its Q-Biologics platform, with the first product BIO-PLY™ in FDA development for infectious, inflammatory, and degenerative diseases.
Who founded Qentoros?: Qentoros was founded by Jessica Gilbertie in 2022.
How much funding has Qentoros raised?: Qentoros has disclosed $605K raised across 2 rounds.
Where is Qentoros headquartered?: Qentoros is headquartered in Blacksburg, US.